Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-center cardiac safety follow-up study of Org 24448 (farampator) recipients
2007-001611-32Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of farampator in schizophrenia, sponsored by Organon & Co. Primary endpoint: Cardiac status assessment. Started Apr 2008; status: completed.
02
Drugs
farampator
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-001611-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001611-32.